Impact of Platelet-Rich Fibrin Combined with Silver Nanoparticle Dressing on Healing Time and Therapeutic Efficacy of Chronic Refractory Wounds.

Introduction: Objective • This study aimed to investigate the clinical value of combining platelet-rich fibrin (PRF) with nano silver (AgNP) dressing in the treatment of chronic refractory wounds. Introduction: Methods • A total of 120 patients with chronic refractory wounds were selected from our hospital between January 2020 and January 2022. The patients were randomly divided into the control group and the study group, with 60 cases in each group. The control group received basic treatment combined with AgNP dressing, while the study group received PRF combined with AgNP dressing. A comparison was made between the two groups in terms of wound healing time, hS-CRP levels, VISUAL analogue scale (VAS) scores, procalcitonin (PCT) levels, clinical efficacy, and complications. Introduction: Results • Before treatment, there were no significant differences in hS-CRP, VAS, and PCT levels between the two groups (P > .05). However, after treatment, the study group showed significantly lower hS-CRP, VAS, and PCT levels compared to the control group (P < .05). The study group also exhibited a shorter wound healing time, a higher rate of excellent and good curative effect (95.00% vs 81.67%) compared to the control group (χ2 = 5.175, P < .05), and a lower incidence of wound complications (6.67% vs 21.67%) compared to the control group (χ2 = 4.386, P < .05). Introduction: Conclusions • The combination of PRF and AgNP dressing can effectively alleviate pain and local inflammation in patients with chronic refractory wounds, improve the wound healing rate, shorten the healing time, and reduce the risk of complications such as infection spread.

The Value of Continuous Closed Negative Pressure Drainage Combined with Antibacterial Biofilm Dressing in Postoperative Wound Healing for Severe Pancreatitis.

Objective: To investigate the application value of continuous vacuum sealing drainage (VSD) combined with antibacterial biofilm hydraulic fiber dressing in wound healing after surgery for severe acute pancreatitis (SAP). Methods: A total of 82 SAP patients who underwent minimally invasive surgery in our hospital from March 2021 to September 2022 were randomly divided into two groups using a random number table method. Each group consisted of 41 cases. Both groups received surgical treatment, with the control group receiving VSD treatment and the observation group receiving VSD treatment combined with antibacterial biofilm hydraulic fiber dressing. The postoperative recovery efficiency, preoperative and postoperative wound area reduction rate, pressure ulcer healing score (PUSH), serum biological indicators (white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT)), and the rate of wound-related adverse reactions were compared between the two groups. Results: There was no statistical difference between the two groups in the time to resume eating (P > .05). However, the wound healing time and hospitalization days in the observation group were significantly shorter than those in the control group (P < .05). After 7 and 14 days of treatment, the wound area reduction rate in the observation group was significantly higher than in the control group, and the PUSH score was significantly lower than in the control group (P < .05). WBC, CRP, and PCT levels in the observation group were lower than in the control group (P < .05). The incidence of wound-related adverse reactions in the observation group (12.20%) was significantly lower than that in the control group (34.15%) (P < .05). Conclusions: The application of VSD combined with antibacterial biofilm hydraulic fiber dressing in the postoperative wound healing of SAP has a significant effect. It improves wound healing efficiency, reduces pressure ulcer scores, decreases inflammation indicators, and lowers the incidence of adverse reactions. While further research is needed to determine its impact on infection and inflammation prevention, this treatment approach shows promise for clinical application.

Design, synthesis and biological evaluation of 3-aryl-7-hydroxy scopoletin derivatives as autophagy activators against tumorigenesis.

A natural product scopoletin, which also contains an ortho-substituted phenolic structure in its skeleton, was found in some medicinal plants. In this study, to develop scopoletin-based autophagy activators, various aryl substitutes were introduced at the 3-positon or 4-position of scopoletin skeleton with the ortho-substituted phenolic structure retained. A total of twenty-three derivatives were synthesized, evaluated for their antiproliferation activity against four cancer cells (MCF-7, HeLa, PC3, and MGC803), and discussed for their structure-activity relationships (SARs). Among these derivatives, 5c was the most potent compound with an excellent improvement of antiproliferation activity against PC3 and MGC803 cells compared to the parental scopoletin. 5c displayed up to 17.9- and 5.7-fold improvement of antiproliferation activities against PC3 and MGC803 cells compared to 5-FU (IC50 = 0.14 µM vs IC50 = 2.50 µM, IC50 = 1.02 µM vs IC50 = 5.81 µM), respectively. Moreover, 5c showed excellent selectivity between cancer cells and one normal cell (GES-1). Further mechanism investigations confirmed that 5c inhibited PC3 and MGC803 cell proliferation via inducing autophagy. Interestingly, 5c also induced mitochondria-mediated apoptosis in PC3 cells but not in MGC803 cells. Moreover, 5c possessed the ability to suppress colony formation and migration of PC3 and MGC803 cells. In addition, 5c arrested the cell cycle at the G2/M phase of PC3 cells.

[Determination of the molecular mass of modified citrus pectin using high performance size exclusion chromatography].

Modified citrus pectin (MCP) is a polysaccharide with anti-tumor growth, anti-invasiveness and anti-metastasis activities. It is of significance to determine the molecular mass and polydispersity of polysaccharide, which could influence pharmacological activities of polysaccharide. To the best of our knowledge, no study has been reported on calculating the molecular mass of MCP by high performance size exclusion chromatography-refractive index detection (HPSEC-RID). A TSK G3000PW(XL) column was used at 40 degrees C, and the mobile phase was composed of 50 mmol/L NH4Ac solution. Pullulan with known molecular mass was chosen as calibration standard to obtain regression equation. Relative molecular mass of MCP can be derived from the regression equation. Relative molecular masses of MCP were obtained: M(n), 21000; M(w), 43000; M(p), 46000; M(z), 66000. The polydispersity index of MCP was 2. The established method is simple, rapid and repeatable for quality control in preparing MCP and it would be also applicable to the study of composition-activity relationship of MCP in the future.